Credit Suisse Ag Intellia Therapeutics, Inc. Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

A detailed history of Credit Suisse Ag transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Credit Suisse Ag holds 134,497 shares of NTLA stock, worth $1.28 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

134,497

Previous 134,180 0.24%

Holding current value

$1.28 Million

Previous $4.09 Million 9.56%

% of portfolio

0.0%

Previous 0.0%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$23.82 - $32.8 $7,550 - $10,397	317 Added 0.24%	134,497 $3.7 Million
Q4 2023 Feb 08, 2024	BUY	$23.16 - $32.34 $289,337 - $404,023	12,493 Added 10.27%	134,180 $4.09 Million
Q3 2023 Nov 13, 2023	SELL	$31.62 - $45.78 $101,848 - $147,457	-3,221 Reduced 2.58%	121,687 $3.85 Million
Q2 2023 Aug 11, 2023	BUY	$34.58 - $46.03 $767,261 - $1.02 Million	22,188 Added 21.6%	124,908 $5.09 Million
Q1 2023 May 10, 2023	BUY	$33.3 - $44.82 $338,427 - $455,505	10,163 Added 10.98%	102,720 $3.83 Million
Q4 2022 Feb 13, 2023	BUY	$33.21 - $62.69 $317,122 - $598,626	9,549 Added 11.5%	92,557 $3.23 Million
Q3 2022 Nov 10, 2022	SELL	$53.92 - $71.7 $47,880 - $63,669	-888 Reduced 1.06%	83,008 $4.64 Million
Q2 2022 Aug 12, 2022	SELL	$38.49 - $76.21 $611,336 - $1.21 Million	-15,883 Reduced 15.92%	83,896 $4.34 Million
Q1 2022 May 16, 2022	BUY	$58.27 - $118.99 $1.67 Million - $3.42 Million	28,702 Added 40.38%	99,779 $7.25 Million
Q4 2021 Feb 14, 2022	SELL	$100.76 - $138.36 $868,450 - $1.19 Million	-8,619 Reduced 10.81%	71,077 $8.41 Million
Q3 2021 Nov 12, 2021	SELL	$132.37 - $176.78 $2.46 Million - $3.28 Million	-18,581 Reduced 18.91%	79,696 $10.7 Million
Q2 2021 Aug 16, 2021	BUY	$60.88 - $161.91 $1.07 Million - $2.86 Million	17,640 Added 21.88%	98,277 $15.9 Million
Q1 2021 May 14, 2021	SELL	$46.59 - $83.68 $1.01 Million - $1.81 Million	-21,649 Reduced 21.17%	80,637 $6.47 Million
Q4 2020 Feb 12, 2021	SELL	$18.83 - $63.53 $491,218 - $1.66 Million	-26,087 Reduced 20.32%	102,286 $5.56 Million
Q3 2020 Nov 13, 2020	BUY	$17.47 - $24.93 $362,275 - $516,973	20,737 Added 19.27%	128,373 $2.55 Million
Q2 2020 Aug 12, 2020	BUY	$11.14 - $22.87 $525,596 - $1.08 Million	47,181 Added 78.04%	107,636 $2.26 Million
Q1 2020 May 13, 2020	BUY	$9.44 - $15.58 $187,148 - $308,873	19,825 Added 48.79%	60,455 $739,000
Q4 2019 Feb 12, 2020	BUY	$10.43 - $17.67 $161,445 - $273,513	15,479 Added 61.54%	40,630 $595,000
Q3 2019 Nov 12, 2019	SELL	$13.07 - $18.51 $13,893 - $19,676	-1,063 Reduced 4.06%	25,151 $335,000
Q2 2019 Aug 14, 2019	BUY	$13.88 - $18.41 $86,264 - $114,418	6,215 Added 31.08%	26,214 $428,000
Q1 2019 May 14, 2019	SELL	$12.79 - $17.62 $84,912 - $116,979	-6,639 Reduced 24.92%	19,999 $341,000
Q4 2018 Feb 13, 2019	BUY	$11.39 - $27.13 $16,766 - $39,935	1,472 Added 5.85%	26,638 $363,000
Q3 2018 Nov 13, 2018	SELL	$25.78 - $32.6 $262,053 - $331,379	-10,165 Reduced 28.77%	25,166 $721,000
Q2 2018 Aug 14, 2018	BUY	$20.02 - $30.79 $101,401 - $155,951	5,065 Added 16.73%	35,331 $967,000
Q1 2018 May 15, 2018	BUY	$19.43 - $34.95 $85,297 - $153,430	4,390 Added 16.97%	30,266 $638,000
Q4 2017 Feb 14, 2018	BUY	$17.39 - $31.12 $40,657 - $72,758	2,338 Added 9.93%	25,876 $498,000
Q3 2017 Nov 14, 2017	BUY	$15.16 - $25.75 $356,836 - $606,103	23,538	23,538 $585,000

Others Institutions Holding NTLA

# of Institutions

316

Shares Held

91.7M

Call Options Held

442K

Put Options Held

880K

View Full List

About Intellia Therapeutics, Inc.

Ticker NTLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,011,800
Market Cap $722M
Description
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...

More about NTLA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account